Raymond J. Tesi's most recent trade in INmune Bio Inc was a trade of 226,000 Option (right to buy) done . Disclosure was reported to the exchange on Dec. 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| INmune Bio Inc | Raymond J. Tesi | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 226,000 | 226,000 | - | - | Option (right to buy) | |
| INmune Bio Inc | Raymond J. Tesi | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Sep 2024 | 15,380 | 15,380 | - | - | Common Stock Warrants (right to buy) | |
| INmune Bio Inc | Raymond J. Tesi | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.38 per share. | 12 Sep 2024 | 15,380 | 1,554,106 (14%) | 0% | 6.4 | 98,048 | Common Stock |
| INmune Bio Inc | Raymond J. Tesi | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 37,882 | 37,882 | - | - | Option (right to buy) | |
| INmune Bio Inc | Raymond J. Tesi | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 160,000 | 160,000 | - | - | Option (right to buy) | |
| INmune Bio Inc | Raymond J. Tesi | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.32 per share. | 19 Apr 2024 | 18,028 | 1,538,726 (14%) | 0% | 8.3 | 149,993 | Common Stock |
| INmune Bio Inc | Raymond J. Tesi | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Apr 2024 | 18,028 | 18,028 | - | - | Common Stock Warrants (right to buy) | |
| INmune Bio Inc | Raymond J. Tesi | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 160,000 | 160,000 | - | - | Option (right to buy) | |
| INmune Bio Inc | Raymond J. Tesi | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.41 per share. | 26 May 2022 | 6,300 | 1,520,698 (14%) | 0% | 6.4 | 40,383 | Common Stock |
| INmune Bio Inc | Raymond J. Tesi | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 130,000 | 130,000 | - | - | Option (right to buy) | |
| INmune Bio Inc | Raymond J. Tesi | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 8.43 per share. | 21 Mar 2022 | 23,724 | 1,514,398 (14%) | 0% | 8.4 | 199,993 | Common Stock |
| INmune Bio Inc | Raymond J. Tesi | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 03 Nov 2021 | 3,626 | 1,490,674 (13%) | 0% | 20 | 72,520 | Common Stock |
| INmune Bio Inc | Raymond J. Tesi | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 27 Oct 2021 | 6,517 | 1,494,300 (13%) | 0% | 20 | 130,340 | Common Stock |
| INmune Bio Inc | Raymond J. Tesi | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 22 Oct 2021 | 23,616 | 1,500,817 (13%) | 0% | 20 | 472,320 | Common Stock |
| INmune Bio Inc | Raymond J. Tesi | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2021 | 30,000 | 270,000 | - | - | Employee Stock Option (right to buy) | |
| INmune Bio Inc | Raymond J. Tesi | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.91 per share. | 25 Aug 2021 | 30,000 | 1,524,433 (14%) | 0% | 3.9 | 117,300 | Common Stock |
| INmune Bio Inc | Raymond J. Tesi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.08 per share. | 07 Jul 2021 | 24,351 | 1,510,933 (14%) | 0% | 20.1 | 488,968 | Common Stock |
| INmune Bio Inc | Raymond J. Tesi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.02 per share. | 07 Jul 2021 | 5,649 | 1,535,284 (14%) | 0% | 20.0 | 113,082 | Common Stock |
| INmune Bio Inc | Raymond J. Tesi | Director, President & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 70,663 | 70,663 | - | - | Option | |
| INmune Bio Inc | Raymond J. Tesi | Director, President & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 59,337 | 59,337 | - | - | Option |